Aligning marketing and sales activities ― from brand planning through execution ― is critical for specialty pharmaceutical companies, where the stakes are high and every patient matters.
With so much on the line, pharma companies with specialty products must plan every move with great precision. Yet complex, limited patient populations, unique distribution channels and patient access challenges make it very difficult. For the most reliable, robust and granular view of specialty market and prescribing dynamics on which to base your critical decisions — turn to IMS.
We bring together the industry’s leading coverage for specialty prescriptions with anonymized patient-level insights to create a new class of key performance indicators, previously unavailable to specialty brand marketing and sales professionals.
Now specialty brands can gain visibility into the dynamic portion of patient and prescriber decisions — including new to therapy, switches and add-ons — to pinpoint where to optimally focus messaging, budget and resources. With IMS’s patient-level, specialty insights you can more precisely determine which patient and prescriber segments would derive the greatest clinical benefits from your product, and align your marketing and sales efforts accordingly.
- Specialty market opportunity assessment
- Market and competitive analysis
- Patient and physician segmentation
- Positioning and messaging
- Brand and sales performance management
- Resource optimization, territory alignment and call planning